Schwarz, Sigrid (NeuroProgen 200601 CEO) |
Chief Executive Officer (CEO) |
NeuroProgen GmbH |
Germany |
Schwarz, Thomas (Instraction GmbH 2009– Managing Director + Board Chairman CLIB2021 before Biotop AG) |
Managing Director |
InstrAction GmbH |
Germany |
Schwarz-Schütte, Patrick (Schwarz Pharma) |
Chief Executive Officer (CEO) |
UCB (Group) |
Germany |
Schwarzkopf, Martina (Russo Partners 201312) |
Public Relations Manager / Investor Relations Manager |
Russo Partners LLC |
United States (USA) |
Schweickart, Nikolaus (Altana AG 200605 CEO) |
Chief Executive Officer (CEO) |
Altana (Group) |
Germany |
Schweickhardt, Wolfram (Germany (govt) 201505 at KfW) |
n. a. |
Germany (govt) |
Germany |
Schweiger, Christian (Shield Therapeutics 2008– CSO + Co-founder before Encysive Pharmaceuticals before Actelion) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Iron Therapeutics (Switzerland) AG |
Switzerland |
Schweikhard, Lutz (Univ Greifswald 201007 Professor + Director of Institute of Physics) |
Professor |
University of Greifswald |
Germany |
Schweins, Thomas (Qiagen 200402– VP Corporate Strategy before Boston Consulting Dusseldorf before Hoechst) |
Corporate Strategy Manager |
Qiagen (Group) |
Netherlands |
Schweitzer, Gretchen (Trophic Comunications 201801 before MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
Schweitzer, Markus |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
Schweizer, Christoph (Dräger 201801 President Corporate Strategy + Business Development) |
Business Development Manager / Strategy Manager |
Dräger (Group) |
Germany |
Schweizer, Pascal (Thermosome GmbH 201604 Managing Director) |
Managing Director |
Thermosome GmbH |
Germany |
Schwenzer, Anette (Promega 201101 Promega GmbH Head Digital Marketing/PR) |
Sales Manager / Marketing Manager |
Promega (Group) |
Germany |
Schwer, Heinz (ViraTherapeutics 201705– CEO before Lanthio Pharma + Sloning BioTechnology CEO + Founder) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
Austria |
Schwerin, Manfred (Leibniz-Gemeinschaft 201109 Head FBN Dummerstorf) |
President/Director/Head Business Group/Unit/Division |
Leibniz-Gemeinschaft |
Germany |
Schwertner-Knoll, Dagmar (BioGenes GmbH 201302 Marketing/Sales Director) |
Sales Manager / Marketing Manager |
BioGenes Gesellschaft für Biopolymere mbH (BioGenes GmbH) |
Germany |
Schwiezer, Jürgen (Roche Diagnostics GmbH –200605– designated CEO Division Roche Diagnostics 200801) |
Chief Executive Officer (CEO) |
Roche (Group) |
Germany |
Schüberg, Staffan (Esteve 202001 CEO before Lundbeck) |
Chief Executive Officer (CEO) |
Esteve (Group) |
Spain (España) |
Schühsler, Helmut M. (TVM) |
n. a. |
TVM (Group) |
Germany |
Schülein, Thomas (Bruker 201308 President of Bruker Nano Analytics division) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
|
Schüler, Julia (BioMedServices 201101– before BioRegion Rhein-Neckar 200910–201012 Managing Director + E&Y Mannheim) |
consulting (economic) |
BioMedServices, Dr. Julia Schüler |
Germany |
Schüller, Alexander (Cellvie 202101 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellvie (Group) |
Switzerland |
Schüller, Frank (Forever Healthy 202101 Managing Director of Kizoo Technology Capital) |
Managing Director |
Forever Healthy (Group) |
|
Schüller, Thorsten (CureVac 201911 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
CureVac (Group) |
Germany |
Schüller, Ulrich |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Schüller, Wolfgang (Lipotec GmbH + Frankfurt BioTech Alliance e. V. before Aventis Research and Technologies 200205) |
Managing Director |
Sanofi (Group) [since May 2011] |
Germany |
Schüren, Reinhard (November AG 200609– CEO) |
Chief Executive Officer (CEO) |
November (Group) |
Germany |
Schürmann, Anja (Biofrontera 200801– Director Marketing before Galderma) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Germany |
Schürmann, Hans |
n. a. |
Holtzbrinck (Group) |
|
Schütte, Georg (BMBF 201202 State Sectretary) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
Schütte, Stefan (Agilent 200903 Senior Marketing Director Liquid Chromatography Business) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
Schütz, Christian (btov Partners 201907 Managing Director) |
Managing Director |
btov Partners (b-to-v Partners AG) |
Switzerland |
Schütze, Karin (CellTool GmbH 201912 Managing Director + Co-Founder) |
Managing Director |
CellTool GmbH |
Germany |
Schüßler, Andrea (Huber & Schüßler 200809 Munich) |
n. a. |
Huber & Schüssler Patentanwälte (Munich) |
Germany |
Schächtele, Christoph (ProQinase 200805 CEO) |
Chief Executive Officer (CEO) |
Klinik für Tumorbiologie Freiburg (KTB) (Tumor Biology Center Freiburg) |
Germany |
Schäfer, Bernd-Josef (Endress+Hauser 201801 Managing Director of Endress+Hauser Flowtec) |
Managing Director |
Endress+Hauser (Group) |
Switzerland |
Schäfer, Elmar (Biogenerix 200503) |
n. a. |
Merckle (Group) |
Germany |
Schäfer, Gerhard (Novartis/Sandoz + before Hexal + Stada + Noll + Azupharma) |
n. a. |
Novartis (Group) |
Germany |
Schäfer, Gisbert (AB SCIEX 201009 Senior Director EMEA) |
Regional manager |
Danaher (Group) |
Germany |
Schäfer, Jochen (GATC Biotech 201011 Director Custom Sequencing) |
Laboratory Manager (industry) |
Eurofins (Group) |
Germany |
Schäfer, Klaus (Altana Pharma 200503) |
n. a. |
Takeda (Group) |
Germany |
Schäfer, Mathias (Univ Cologne 201004 Head Mass Spec Lab at Institute for Organic Chemistry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Cologne (Universität zu Köln) |
Germany |
Schäfer, Ralf (Bruker Corp 201303 Bruker Daltonics MADI-TOF Product Manager) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
Schäfer-Korting, Monika (FU Berlin 200507) |
n. a. |
Freie Universität Berlin (FU Berlin, Free University Berlin) |
Germany |
Schäferkordt, Jan |
n. a. |
Miltenyi Biotec (Group) |
Germany |
Schäffer, Michael (Probiodrug 201810– CBO joined 201808 as EVP Business + Strategy before Crelux + Sireen) |
Business Development Manager / Strategy Manager |
Vivoryon (Group) |
Germany |
Schöfer, Sebastian (High-Tech Gründerfonds 201409 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Schön, Heiko (Merck (DE) 201508– Manager Group Strategy joined Merck in 2005) |
Corporate Strategy Manager |
Merck (DE) (Group) |
Germany |
Schön-Feltes, Silvia (NRW 201010 PROvendis responsible for Biology) |
IP Manager |
Provendis (Patentagentur NRW) |
Germany |
Schönauer, David (Aminoverse 202003– CEO before SeSaM-Biotech GmbH 201212–202002 Managing Director) |
Chief Executive Officer (CEO) |
Aminoverse B.V. |
Netherlands |
Schöndorf, Martin (Laboratoires Réunis 201711 Director Business Unit) |
n. a. |
Laboratoires Réunis (LU) |
Luxembourg |
Schöndube, Jonas (Cytena GmbH 201403– Managing Director + Co-Founder) |
Managing Director |
Cellink (Group) |
Germany |
Schönfeld, Kirsten (Q-Bioanalytic GmbH 200902 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
Schönfeld, Wolfgang (Eucodis 200808c CEO) |
Chief Executive Officer (CEO) |
Eucodis Bioscience (Group) |
Austria |
Schöning, Jan (Boehringer 201509 Head Global Technology + Innovation Management Biopharmaceuticals) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
Scimeca, Dario (Precision BioSciences 201906– General Counsel before Genentech + Cooley LLP + Heller Ehrman LLP) |
General Counsel / Chief Legal Officer (CLO) |
Precision BioSciences (Group) |
United States (USA) |
Scodari, Joseph C. (Actelion –201107 Board Director RESIGNED 8/11) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Scordis, Phil (UCB 201209 Director of Informatics) |
IT manager |
UCB (Group) |
Belgium |
Scots-Knight, Denise (formerly Pollard-Knight) (Mereo BioPharma 201507 CEO before Managing Partner at Phase4 Ventures) |
Chief Executive Officer (CEO) |
Mereo BioPharma Group Ltd. |
United Kingdom (GB) |
Scott, Kalina (Polyphor 201706– CFO before Bank am Bellevue + UBS + KPMG) |
Chief Financial Officer (CFO) |
Polyphor Ltd. (SIX: POLN) |
Switzerland |
Scott, Nerida (JnJ 202009 Head JnJ Innovation EMEA) |
Business Development Manager / Strategy Manager |
Johnson & Johnson (JnJ) (Group) |
United Kingdom (GB) |
Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board) |
Chief Executive Officer (CEO) |
Basilea (Group) |
Switzerland |
Scriba, Jürgen (Advalytix co-founder) |
n. a. |
Danaher (Group) |
Germany |
Searle, Susan (Imperial Innovation 200511 CEO) |
Chief Executive Officer (CEO) |
Touchstone Innovations (Group) |
United Kingdom (GB) |
Sebald, Walter |
n. a. |
University of Würzburg |
Germany |
Sebastian, Dirk (Ganymed Pharmaceuticals AG 201309 CFO + COO) |
Chief Financial Officer (CFO) |
Astellas (Group) |
Germany |
Sebhatu, Jared (German Accelerator Life Sciences 201604 Program Director Germany before VDI) |
Business Development Manager / Strategy Manager |
digital health transformation eG (dht) |
Germany |
Sedgwick, Jonathon (Boehringer 201710 VP + Global Head Cancer Immunology + Immune Modulation Research) |
Research & Development Manager |
Boehringer Ingelheim (Group) |
Germany |
Seeberger, Peter H. (MPI of Colloids and Interfaces 2009– Director before ETH Zurich Prof before MIT Prof) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
Seefeldt, Christian H. (MeVis Medical Solutions 200901–201009 CFO resigned 201009 before Saperion AG + Haitec AG) |
Chief Financial Officer (CFO) |
Varian Medical Systems (Group) |
Germany |
Seegers, Christian (Berlin (govt) 201111 Senior Investment Manager Life Science at IBB Beteiligungsges) |
Investment Manager |
Berlin (govt region) |
Germany |
Seehofer, Horst (Germany (govt) 200809 Minister of Agriculture) |
Minister |
Germany (govt) |
Germany |
Seewald, Michael (Bayer HealhCare 200506) |
n. a. |
Bayer (Group) |
Germany |
Seewald, Sascha (Caterna GmbH 201101 Managing Director) |
Managing Director |
Caterna Vision GmbH |
Germany |
Segeberg, Friederike (Merck (DE) 202002 Head Media Relations) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
Segerros, Andreas (Sunstone Capital 201502 Partner) |
Partner (venture partner) |
Eir Ventures |
Sweden |
Seghezzi, Graziano (Sofinnova Partners 200806 Partner) |
Partner (venture partner) |
Sofinnova (Group) |
France |
Sehlmeyer, Rasa (HighQu GmbH 201504 Managing Director) |
Managing Director |
HighQu GmbH |
Germany |
Seibert, Daniel (Life Technologies 201105 CFO of Geneart AG LEFT Geneart BEFORE 7/12) |
Chief Financial Officer (CFO) |
Thermo Fisher (Group) |
Germany |
Seibert, Gloria Sophia (Temedica 202001 Managing Director + Co-Founder) |
Managing Director |
Temedica GmbH |
Germany |
Seidel, Guido (Wacker 202007 Managing Director of Wacker Biotech GmbH + Head of Biopharma Business) |
Managing Director |
Wacker (Group) |
Germany |
Seidel, Mathias (Denk Pharma 201611 Business Development) |
Business Development Manager / Strategy Manager |
Denk Pharma (Group) |
Germany |
Seidel, Uwe (XotonicsMED GmbH 201607 Managing Director) |
Managing Director |
XotonicsMED GmbH |
Germany |
Seidel, Wolfgang (Advigen 201201 before Innogenetics 2005–2009 VP BusDev + Bayer Pharma 1981–2004) |
Consultant (economic/technology) |
Advigen Dr. Wolfgang Seidel Biotechnology Consulting |
Germany |
Seidelmann, Oliver (Chiroblock GmbH 201109 Managing Director + co-founder) |
Managing Director |
ChiroBlock GmbH |
Germany |
Seidl, Andreas (Leukocare 202103 COO) |
Chief Operating Officer (COO) |
Leukocare AG |
Germany |
Seidl, Gerd (Bayer Innovation GmbH 200606) |
n. a. |
Bayer (Group) |
Germany |
Seidler, Jörg (SGS 201110 Project Scientist at SGS M-Scan GmbH) |
Laboratory Manager (industry) |
SGS (Group) |
Germany |
Seifert, Martin (Genomatix 201103 CEO existent before 200808 VP Business Development + Consulting) |
Chief Executive Officer (CEO) |
Genomatix Software (Group) |
Germany |
Seifert, Roland (MHH 201110 Professor + Director of Institute of Pharmacology) |
Professor |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
Seipelt, Joachim (Nuvonis Technologies 201803 Head of Business Development) |
Business Development Manager / Strategy Manager |
Nuvonis Technologies GmbH |
Austria |
Seizinger, Bernd R. (GPC Biotech 199810– CEO before BMS Pharma Research Institute) |
Chief Executive Officer (CEO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
Sekhar, P. Chandra (Brand 200705 Consultant Indian Contact) |
n. a. |
Brand (Group) |
Germany |
Sekhri, Paul J. (eGenesis 201901– CEO before Lycera + Sanofi + Teva + TPG Biotech + Cerimon + Ariad + Sprout) |
Chief Executive Officer (CEO) |
eGenesis Inc. |
United States (USA) |
Selbach, Matthias (Helmholtz 201402– Professor for Proteomics Research at MDC Berlin) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
Selick, Barry (Threshold Pharmaceuticals 200607 CEO) |
Chief Executive Officer (CEO) |
Threshold Pharmaceuticals Inc. (Nasdaq: THLD) |
United States (USA) |
Selvaraju, Raghuram (Ram) (Relief Therapeutics 202010 Board Chairman) |
Board member, non-executive |
Relief Therapeutics (Group) |
Switzerland |
Selzer, Sebastian (PS Biotech GmbH 201305 Managing Director + Co-Founder) |
Managing Director |
PS Biotech GmbH |
Germany |
Semmler, Hans-Christian (HCS Beteiligungsgesellschaft 201309 Managing Director) |
Managing Director |
HCS Beteiligungsgesellschaft mbH |
Germany |